Results 81 to 90 of about 4,214 (170)

Reduction in ATP levels triggers immunoproteasome activation by the 11S (PA28) regulator during early antiviral response mediated by IFNβ in mouse pancreatic β-cells.

open access: yesPLoS ONE, 2013
Autoimmune destruction of insulin producing pancreatic β-cells is the hallmark of type I diabetes. One of the key molecules implicated in the disease onset is the immunoproteasome, a protease with multiple proteolytic sites that collaborates with the ...
Wieke Freudenburg   +10 more
doaj   +1 more source

Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits.

open access: yesPLoS Biology
Defective autophagy is linked to proinflammatory diseases. However, the mechanisms by which autophagy limits inflammation remain elusive. Here, we found that the pan-FGFR inhibitor LY2874455 efficiently activated autophagy and suppressed expression of ...
Jiao Zhou   +6 more
doaj   +1 more source

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders

open access: yesEBioMedicine, 2018
Accumulation of aggregated α-synuclein into Lewy bodies is thought to contribute to the onset and progression of dopaminergic neuron degeneration in Parkinson's disease (PD) and related disorders.
Scott Ugras   +14 more
doaj   +1 more source

Recent Advances in the Development of Immunoproteasome Inhibitors as Anti-Cancer Agents: The Past 5 Years

open access: yesMolecules
The immunoproteasome (iCP) is an isoform of the 20S proteasome that is expressed in response to cellular stress or inflammatory stimuli. The primary role of the iCP is to hydrolyze proteins into peptides that can be loaded into the MHC-I complex.
Francesca Mancuso   +5 more
doaj   +1 more source

Immunoproteasomes [PDF]

open access: yes, 2012
Deborah A. Ferrington, Dale S. Gregerson
openaire   +2 more sources

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2019
Proteasome inhibition is a promising strategy for the treatment of multiple myeloma; unfortunately, this disease is often associated with an increasing chemoresistance.
Roberta Ettari   +9 more
doaj   +1 more source

CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome

open access: yesScientific Reports
Various factors have been implicated in the pathogenesis of ulcerative colitis (UC), with immune system failure being the most important one. Calcitonin gene-related peptide (CGRP), a neuropeptide with two isoforms, CGRPα and CGRPβ, has been reported to ...
Tatsuya Shibao   +7 more
doaj   +1 more source

Dominant-negative PSMB10 disrupts immunoproteasome assembly and leads to transient T lymphopenia. [PDF]

open access: yesJ Hum Immun
Ghosh S   +24 more
europepmc   +1 more source

Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly. [PDF]

open access: yesAm J Hum Genet
Wijngaard R   +38 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy